US Rep. Gaetz’s diagnosis of what’s driving insulin costs misses the root cause

By | April 22, 2022
At the end of March, after the House passed a bill that would cap the cost of insulin at $35 per month for insured consumers, Rep. Matt Gaetz (R-Fla.) tweeted about why he voted against the legislation.